On March 24, the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network Health Advisory to clinicians and public health officials regarding the increase in global and U.S.

All MOC point requests and CE credit claims must be submitted by September 4, 2025. Credit claiming will not be available after this date. A pop-up will display to guide you through logging credit for ...

Please review the following abstract policies when preparing your submission. You can also review the Abstract Policy FAQs page for answers to common questions asked by submitters.

The 2025 ASCO Annual Meeting Abstract Submitter is closed. For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked below.

Start planning before you arrive at McCormick Place. View the information below so you know where to go for all of your needs while you’re at the Meeting, including onsite childcare and accessibility ...

Explore resources for getting to Chicago and navigating the ASCO Annual Meeting online and in-person.

The Career Fair offers a convenient way for attendees to explore available career options with representatives from hospitals, academic institutions, private practices, and leading firms in the field ...

Formerly the JCO Journals Lounge, JCO Central is a place of community for oncology authors, researchers, or anyone interested in publishing. Meet with JCO Journals editors and discuss manuscript ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers ...

Two topics critical to the future of cancer care and research—and central to ASCO's mission—were the focus of a pair of oncology podcasts that dropped in April. The NRG Oncology podcast, released on ...

Members of the Association for Clinical Oncology (ASCO) were on Capitol Hill on April 8, 2025, for the 10th annual ASCO Advocacy Summit, where they met with lawmakers to discuss critical issues in ...

The U.S. Supreme Court issued an opinion on Wednesday, April 2, that the Food and Drug Administration (FDA) was within its power to regulate the sale of certain flavored e-cigarette products. The case ...